Characterization of Depressive Symptoms Trajectories After Breast Cancer Diagnosis in Women in France
Cécile Charles(Université de Bordeaux), Sarah Dauchy(Institut Bergonié), A. Bardet(Institut Gustave Roussy), Sibille Everhard(Assistance Publique – Hôpitaux de Paris), Nicolás Ramoz(Inserm), Barbara Pistilli(Institut Gustave Roussy), Agnès Dumas(Inserm), Anne‐Laure Martin(UniCancer Group), Asma Dhaini Mérimèche(Délégation Centre-Est), Marina Rousseau-Tsangaris, Olivier Trédan(Centre Léon Bérard), Antonio Di Meglio(Inserm), Julie Havas(Inserm), Paul Cottu(Université Paris Sciences et Lettres), Fabrice André(Inserm), Alain Viari(Centre National de la Recherche Scientifique), Alicia Larive(Inserm), Stefan Michiels(Institut Gustave Roussy), Gwenn Menvielle(Inserm), Seyive-yvon-arnauld Gbenou(Inserm), Emilie Thomas(Université Claude Bernard Lyon 1), Christelle Jouannaud(Institut Jean Godinot), Inês Vaz-Luís(Inserm), Charles Coutant(Université de Bourgogne), Laurence Vanlemmens(Centre Oscar Lambret), Christelle Levy(Centre François Baclesse), Florence Lerebours(Institut Curie), Philip Gorwood(Inserm), Mayssam El-Mouhebb(Inserm)
Cited by 48
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
|New England Journal of Medicine|2015|1.6k